Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10829760 Nucleic acid molecules inducing RNA interference, and uses thereof
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 29 Jul, 2023
"Resolve patent citation"
Golden AI
edited on 29 Jul, 2023
Infobox
Patent Citations Received
US Patent 11446394 Lipid nanoparticle formulations comprising lipidated cationic peptide compounds for nucleic acid delivery
0
Edits on 21 Jul, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI
edited on 21 Jul, 2023
Edits made to:
Infobox
(
-1
properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10829760
0
0
Edits on 19 Jul, 2023
"update inverses"
Golden AI
edited on 19 Jul, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11701434 Tertiary amino lipidated cationic peptides for nucleic acid delivery
0
Edits on 28 Apr, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 28 Apr, 2023
Infobox
Patent Citations
US Patent 10059949 Treatment of age-related macular degeneration using RNA complexes that target MYD88 or TLR3
0
Edits on 3 Apr, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 3 Apr, 2023
Infobox
Patent Citations Received
US Patent 11446394 Lipid nanoparticle formulations comprising lipidated cationic peptide compounds for nucleic acid delivery
0
Edits on 1 Apr, 2023
"Entity importer update"
Golden AI
edited on 1 Apr, 2023
Infobox
Is a
Patent
0
Patent Applicant
OliX Pharmaceuticals
0
Current Assignee
OliX Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
10829760
0
Date of Patent
November 10, 2020
0
Patent Application Number
16220030
0
Date Filed
December 14, 2018
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10829760
0
Patent Citations
US Patent 10059949 Treatment of age-related macular degeneration using RNA complexes that target MYD88 or TLR3
0
US Patent 10064801 RNA complexes that inhibit melanin production
0
US Patent 10125362 RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor
0
US Patent 10214744 Nucleic acid molecules inducing RNA interference, and uses thereof
0
US Patent 10358648 Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1
0
Patent Citations Received
US Patent 11446394 Lipid nanoparticle formulations comprising lipidated cationic peptide compounds for nucleic acid delivery
0
Patent Primary Examiner
Jane J Zara
0
Edits on 30 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 30 Mar, 2023
Infobox
Patent Citations
US Patent 10064801 RNA complexes that inhibit melanin production
0
Edits on 25 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 25 Mar, 2023
Infobox
Patent Citations
US Patent 10358648 Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1
0
Edits on 27 Sep, 2022
"update citations for inverse infoboxes"
Golden AI
edited on 27 Sep, 2022
Infobox
Patent Citations
US Patent 10358648 Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1
0
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI
edited on 25 Sep, 2022
Infobox
Patent Citations
US Patent 10059949 Treatment of age-related macular degeneration using RNA complexes that target MYD88 or TLR3
0
Edits on 25 Sep, 2022
"update citations for inverse infoboxes"
Golden AI
edited on 25 Sep, 2022
Infobox
Patent Citations
US Patent 10214744 Nucleic acid molecules inducing RNA interference, and uses thereof
0
"update citations for inverse infoboxes"
Golden AI
edited on 25 Sep, 2022
Infobox
Patent Citations
US Patent 10125362 RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor
0
Edits on 23 Sep, 2022
"Entity importer update"
Golden AI
edited on 23 Sep, 2022
Infobox
Is a
Patent
0
Patent Applicant
OliX Pharmaceuticals
0
Current Assignee
OliX Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
10829760
0
Date of Patent
November 10, 2020
0
Patent Application Number
16220030
0
Date Filed
December 14, 2018
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10829760
0
Patent Citations
US Patent 10059949 Treatment of age-related macular degeneration using RNA complexes that target MYD88 or TLR3
0
US Patent 10064801 RNA complexes that inhibit melanin production
0
US Patent 10125362 RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor
0
US Patent 10214744 Nucleic acid molecules inducing RNA interference, and uses thereof
0
US Patent 10358648 Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1
0
Patent Citations Received
US Patent 11446394 Lipid nanoparticle formulations comprising lipidated cationic peptide compounds for nucleic acid delivery
0
Patent Primary Examiner
Jane J Zara
0
Edits on 21 Sep, 2022
"update inverses"
Golden AI
edited on 21 Sep, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11446394 Lipid nanoparticle formulations comprising lipidated cationic peptide compounds for nucleic acid delivery
0
Edits on 17 Jun, 2022
"Entity importer update"
Golden AI
edited on 17 Jun, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10829760
Edits on 7 Feb, 2022
"Created via: Entity Importer"
Golden AI
created this topic on 7 Feb, 2022
Edits made to:
Infobox
(
+14
properties)
US Patent 10829760 Nucleic acid molecules inducing RNA interference, and uses thereof
Infobox
Is a
Patent
Patent applicant
OliX Pharmaceuticals
Current assignee
OliX Pharmaceuticals
Patent jurisdiction
United States Patent and Trademark Office
Patent number
10829760
Date of patent
November 10, 2020
Patent application number
16220030
Date Filed
December 14, 2018
Patent citations
US Patent 10059949 Treatment of age-related macular degeneration using RNA complexes that target MYD88 or TLR3
US Patent 10064801 RNA complexes that inhibit melanin production
US Patent 10125362 RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor
US Patent 10214744 Nucleic acid molecules inducing RNA interference, and uses thereof
US Patent 10358648 Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1
Patent primary examiner
Jane J Zara
Find more entities like US Patent 10829760 Nucleic acid molecules inducing RNA interference, and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE